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Background: Human papillomavirus (HPV) infection causes cervical cancer and premalignant lesions of the cervix.
Prevalence of HPV infection and HPV genotypes vary among different regions. However there is no data on the
prevalence of HPV infection and HPV genotypes from southwest China. This study was undertaken to determine
the prevalence of and risk factors for HR-HPV infection in Qujing of Yunnan province, southwest China to provide
comprehensive baseline data for future screening strategies.
Methods: A sample of 5936 women was chosen by the multi-stage stratified cluster sampling method with
selection probabilities proportional to size (PPS). An epidemiological questionnaire was conducted via a face-to-face
interview and cervical specimens were taken for HPV DNA testing by Digene Hybrid Capture 2 (HC2) test. HPV
Genotyping Reverse Hybridization Test was used for HPV genotyping. Proportions were compared by Chi-squared
tests, and logistic regression was utilized to evaluate risk factors.
Results: The median age was 38 years and the inter-quartile range was from 31 years to 47 years. 97.3% of the
study population was Han nationality. Overall prevalence of HR-HPV infection was 8.3% (494/5936) and bimodal age
distribution of HPV infection was observed. The five most prevalent HR-HPV genotypes were HPV-16(3.4%), HPV-56
(1.7%), HPV-58(1.4%), HPV-33(1.2%) and HPV-52(0.88%). Multiple HPV infections were identified in 50.5% (208/412) of
the positive genotyping specimens. Multivariate logistic regression model indicated that parity (OR = 1.35, 95% CI:
1.18-1.53, p < 0.0001) was a risk factor for HR-HPV infection, and age of 50–65 years (OR = 0.60, 95% CI: 0.45-0.80,
p = 0.0005), being married or in stable relationship (OR = 0.55, 95% CI: 0.31-0.96, p = 0.035) were protective factors.
Conclusions: This study provided baseline data on HR-HPV prevalence in the general female population in Qujing
of Yunnan province, southwest China. The finding of multiple HPV infections and bimodal age distribution revealed
that HPV screening is necessary for perimenopausal women in future.
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 The resident women registry of Qujing, 2009  
 9 Districts of Qujing City †
 Qilin central city zone   +   Counties  
Community units Township * + Towns
Urban areas Rural areas 
 Community Residents’ Committee    Villages  
 Individual #
Figure 1 Strategy of sampling. † Qilin central city zone, Xuanwei
city, and 7 counties. * The town where the local government of the
county located. # Individuals were drawn up with simple random
sampling method. 9 age strata with PPS were defined in order to
maintain a large enough sample size for statistical power.
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Cervical cancer is the second most common cancer in
women worldwide. [1] More than 100 HPV types have
been identified and nearly 40 types are known to infect
the genital tract [2]. HPV 16 and 18 have been shown to
be causative in the etiology of cervical cancer [3].
Women with persistent infection with oncogenic HPV
subtypes may develop cervical cancer.
There are about 20 high-risk subtypes of HPV asso-
ciated with cervical cancer and precancerous lesions. [3]
Overall, HPV-16 and HPV-18 account for approximately
70% of all cervical cancer diagnosed worldwide each year
[4]. HPV genotypes differ greatly in their geographic dis-
tribution [5,6]. However, there is no data on the preva-
lence of HPV infection from southwest China. Qujing
located at an altitude of 2000 meters in southwest China.
As the second largest city of Yunnan province, the popu-
lation is 6.16 million, and there are various ethnic
groups. This study seeks to describe the prevalence of
HPV infection, HPV genotype distribution as well as risk
factors for HR-HPV infection in the general female
population of Qujing, Yunnan province, southwest
China to provide comprehensive baseline data for asses-
sing its potential impact on cervical pathology and fu-
ture screening strategies of cervical cancer in China.
Methods
Study population and survey sampling design
This cross-sectional population-based study was con-
ducted in Qujing City during June to July 2010. The
study population comprised all resident women between
the ages of 18 to 65 years. The sample size was calcu-
lated on the basis of an expected prevalence of HPV in-
fection, derived from previous studies [7,8]. The formula
was as following:
n ¼ uα




n0: estimated sample size;
π: expected prevalence of HPV infection, 5% was used;
δ: allowing within 15% of the range for a prevalence of
5%, δ= 0.15π;
α= 0.05, uα= 1.96.
In the expectation of a response rate of 80% and
expanded sample size of 150%, the sample size was
adjusted using n = 1.5n0: 0.80 = 6083. The estimated sam-
ple size for the survey was 6100 rounded to the nearest
hundred. Non-contactables were defined as individuals
who were not contactable on three occasions, and refu-
sals defined as individuals who declined to participate in
the study. And women who had a hysterectomy, were
menstruating or pregnant at the time of the study wereexcluded. Sample size supplement is not necessary if
non-contactables and refusals account for less than 20%.
A multi-stage stratified cluster sampling method with
selection probabilities proportional to size (PPS) was
designed to recruit participants, based on the resident
women registry of Qujing, 2009. The stratification fac-
tors included geographical area and age. Qujing City was
comprised of 9 districts, including Qilin central city
zone, Xuanwei city, and 7 counties. Urban area was
defined as community units of Qilin and townships (the
town where the local government of the county located)
of the counties. Rural area was defined as rural villages
of counties. In order to maintain a large enough sample
size for statistical power within each strata, 9 age strata
with the proportion to size were defined. The sampling
strategy is shown in Figure 1.
In the first stage, 4 districts were taken from the 9 dis-
tricts of Qujing, including Qilin central city zone and 3
counties of Huize, Zhanyi and Luliang. In the second
stage, 3 community units from Qilin, one township and
4 towns from each county were taken with probability
proportional to size. The third stage involved sampling
of 6 communities within each community units and 3
villages within each town. Therefore, 72 study sites and
85 individuals from each site were recruited in the sur-
vey. Finally, 85 eligible women provided 9 age strata
from each selected area were drawn up with simple ran-
dom sampling method, based on the local resident
women registry. The four-stage stratified cluster sam-
pling method is shown in Table 1.
Table 1 Multi-stage stratified cluster sampling method
Stage 1 Stage 2 Stage 3 Stage 4 Sample size
Urban areas Central city zone Community units / Township Community Residents’ Committee Individuals
×1 ×6 ×6 ×85 3060
Rural areas Counties Towns Villages Individuals
×3 ×4 ×3 ×85 3060
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Verbal informed consent was obtained before the
questionnaire interview. Participants were asked to
complete a questionnaire via a face-to-face interview,
which was designed to elicit socio-demographic status,
sexual behavior, history of sexually transmitted infec-
tion (STI), parity, and other probable risk factors for
cervical cancer. The questionnaire was piloted on 85
outpatients from gynecological clinic in Peking Union
Medical College Hospital (PUMCH). The internal
consistency reliability (Cronbach’s α) for the full scale
was 0.825. Furthermore, face validity and content val-
idity of the questionnaire were both confirmed by epi-
demiologists and experts from Department of
Obstetrics and Gynecology, PUMCH. The results indi-
cated that the questionnaire had good reliability and
validity.
Cervical specimen and HR-HPV detection
Informed consent was obtained before the collection of
the cervical specimens. Samples of exfoliated cervical
cells were collected with DNAPap cervical sampler
brush (Digene) during gynecological examinations. The
sampler was inserted 1–1.5 cm into the endocervical
canal and rotated 3–5 full turns in counterclockwise dir-
ection. The cervical sampler was then placed into trans-
port medium and stored at 4°C. HR-HPV detection was
carried out using the Digene Hybrid Capture 2 W (HC2)
test according to the manufacture’s instructions, as
described previously. The results are given as a relative
light unit (RLU) ratio and a positive result was defined
as RLU/Co ≥ 1.00 (5000 copies of HPV genome).
HPV genotyping
Genotyping was carried out by HPV Genotyping Reverse
Hybridization Test RUO detection kit. Phenol-
chloroform was used to extract HPV DNA from the re-
sidual of HC2 positive samples. And the human β-globin
gene was used as internal control (IC) to verify the qual-
ity for polymerase chain reaction (PCR). DNA of speci-
mens with negative internal control amplification result
were re-extracted and re-amplified. GP5+/6+ consensus
primers were used according to the manufacture’s
instructions [9].
HPV Genotyping Reverse Hybridization Test identifies
18 high risk or probably high risk HPV genotypes.Besides 13 HR-HPV genotypes covered by HC2 (includ-
ing HPV-16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59 and
68), there are 5 other HPV genotypes that are not
included in the current HC2 probe cocktail (including
HPV-26, 53, 66, 73 and 82) [10].
The final results were detected by colorimetric
change on the membrane strip immortalized with
type-specific oligonucleotides probes. All procedures
were carried out according to the manufacture's
instructions. HR-HPV positive cases were defined as
those with single-type (a single HR type) infection and
those with multiple-type (two or more HR types) in-
fection. Type-specific prevalence included that in both
single-type and multiple-type infection [11].
Quality assurance and quality control
Several efforts were made to standardize all procedures
in each study site. Manuals were written with instruc-
tions on how to conduct the fieldwork, interviewing,
collecting cervical samples, processing and storing the
samples collected. The training program for doctors and
crew of local stuff was held a week before investigation.
Data were key-entered twice by two experienced typists.
Independent databases were formed and were compared
with each other. Any mismatch was corrected after
inter-comparison of the databases and a proportion of
10% of the records in the final database were drawn up
randomly for re-correction manually.
For the laboratory tests, HPV DNA testing by the
HC2 was conducted using the same commercial kit
and the same machine in local lab of Qujing. Cervical
samples were transported to central lab in Shenzhen
for HPV genotyping thereafter. All of the laboratory
technicians were blinded to the clinical profile of the
clients. HPV genotyping were independent of HPV
DNA tests.
Ethical approval was granted by the Research Ethics
Committee of Peking Union Medical College Hospital,
Peking Union Medical College & the Chinese Academy
of Medical Sciences.
Statistical analysis
Descriptive statistics (medians and proportions) were
utilized to characterize the variables. Proportions were
compared using Chi-squared tests. Odds ratios (ORs)




















































Figure 2 Age-specific prevalence for HR-HPV infection and 95% CI.
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zel analysis) to estimate independent risk factors for
HR-HPV infection. Age and variables associated with













Any HR types 412 6.9 9.4 7.0 5.0
16 203 3.4 2.2 4.4 2.4
18 45 0.8 0.5 0.7 1.0
26 4 0.07 0 0.1 0
31 40 0.7 1.1 0.9 0
33 72 1.2 2.4 0.7 0.6
35 9 0.15 0 0.1 0.1
39 44 0.74 2.1 1.6 0.3
45 15 0.25 0.5 0 0.2
51 17 0.29 0.3 0.1 0.2
52 52 0.88 1.6 0.8 0.6
56 103 1.7 1.1 1.2 2.6
58 84 1.4 1.6 2.3 0.6
59 7 0.12 0.3 0 0.2
66 31 0.52 1.3 0.5 0.6
68 19 0.32 0 0.4 0.3
Single 204 3.4 3.5 4.6 2.9
Multiple 208 3.5 5.9 2.5 2.1
HPV: human papillomavirus, No.: number, HR: high-risk.
*The prevalence of an individual type or category included detection of this type omodel were included as candidates in multivariate
model. Parity, age of 50–65 years and marital status
were included in the final model by stepwise













6.9 5.4 7.7 8.7 8.1 8.5
4.0 3.2 1.8 5.0 3.2 3.8
1.0 0.4 0.6 2.0 0 0
0 0 0.3 0.1 0 0
0.7 1.2 0.9 0 0.8 0.7
0.8 0.7 1.2 0 5.0 3.3
0.4 0.2 0.1 0 0 0
0.5 0.4 0.4 1.1 0.8 0
0 0.6 0.3 0 0.5 0.7
0.4 0.4 0.4 0.4 0.3 0
1.1 0.7 0.6 1.1 1.0 0.7
1.5 1.0 2.2 1.3 2.1 3.3
1.0 1.0 1.5 2.0 0.8 3.7
0.1 0 0 0.4 0 0.4
0.3 0.1 0.5 1.1 0.5 0.4
0.4 0.1 0.6 0.2 0.5 0
3.7 2.8 2.9 2.9 3.9 4.4
3.2 2.6 4.7 5.8 4.2 4.1
r category in both single- and multiple-type infection.
Table 3 Major risk factors for HR-HPV infection adjusted for age
Characteristic Overall No. † HPV DNA positive No. (%) P value OR (95%CI)
Age (years) 0.72
18-29 1230 112 (9.1) 0.75 (0.49-1.15)
30-39 2012 157 (7.8) 1.30 (1.09-1.58)
40-49 1594 112 (7.0) 1 (Ref)
50-65 1100 113 (10.3) 0.58 (0.41-0.81)
Race
The Han nationality 5501 461 (8.4) 1 (Ref)
Minority 155 15 (9.7) 0.566 0.86 (0.50-1.48)
Region
Urban areas 2977 276 (9.3) 0.005 1.31 (1.09-1.58)
Rural areas 2959 218 (7.4) 1 (Ref)
Income per year
<4000¥ 2761 209 (7.6) 1 (Ref)
≥4000¥ 2781 258 (9.3) 0.013 0.78 (0.65-0.95)
Marital status
Married or in stable relationship 5471 449 (8.2) <0.0001 0.37 (0.23-0.58)
Unmarried* 159 24 (15.1) 1 (Ref)
Education
Primary/Junior school 4196 344 (8.2) 1 (Ref)
High school/University 1471 132 (9.0) 0.300 0.89 (0.72-1.11)
Smoking
Ever smoked 207 16 () 0.731 0.91 (0.54-1.53)
Never 5379 450 () 1 (Ref)
Age at first intercourse
≤17 41 16 (7.8) 1 (Ref)
≥18 5599 459 (8.2) 0.100 1.39 (0.81-2.38)
Age of menarche
≤12 407 34 (8.4) 1 (Ref)
≥13 5257 444 (8.4) 0.961 1.01 (0.70-1.46)
Delivery
≤2 4533 381 (8.4) 1 (Ref)
≥3 702 52 (7.4) 0.372 1.26 (0.92-1.73)
Oral contraceptive pills
Never 5486 456 (8.3) 0.22 1.48 (0.82-1.66)
Ever 110 13 (11.8) 1 (Ref)
Life time sexual partners
1 4924 407 (8.3) 1 (Ref)
≥2 57 6 (10.5) 0.470 0.77 (0.33-1.80)
Husband’s life time sexual partners
1 5114 422 (8.3) 1 (Ref)
≥2 107 14 (13.1) 0.078 1.67 (0.95-2.96)
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Table 3 Major risk factors for HR-HPV infection adjusted for age (Continued)
Menopause
Yes 867 91 (10.5) 1 (Ref)
No 4882 391 (8.0) 0.325 1.23 (0.82-1.83)
† Numbers did not always add up to total due to missing data.
* Unmarried includes single, divorced, separated and widowed.
OR= odds ratio; CI = confidence interval.
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Windows (SAS Institute Inc., USA). A level of 0.05 was
chosen to indicate statistical significance.
Results
Qujing is the second largest city of Yunnan province in
southwestern China, with an average altitude of 2000 m.
It has a population of 6 million and has eight ethnic
groups. Because of the limited medical resources, cer-
vical cancer screening is not widely utilized, especially in
rural areas of Qujing. Of the 6116 women who partici-
pated in the study, 180 were excluded because of
inadequate cytology specimen, negative β-globin or inad-
equate questionnaire information, leaving a total of 5936
women included in the statistical analyses. The median
age was 38 years and the inter-quartile range was from
31 years to 47 years. 97.3% of the study population was
Han nationality.
HR-HPV prevalence
Of the 5936 detected cervical samples, 494(8.3%) were
HR-HPV positive by the HC2 test. The prevalence of
HR-HPV ranged from 11.5% (95% CI: 8.3%-14.7%)
among women aged 18–24 years to 6.0% (95% CI: 4.4%-
7.7%) among women aged 40–44 years. Nevertheless, a
relatively high prevalence of 11.2% (95% CI:8.1%-14.4%)
for HR-HPV among women aged 55–59 was observed
(χ2 = 18.343,P= 0.019). Figure 2 shows the age-specific
prevalence for HR-HPV infection.
HPV genotypes
Among the 494 HPV positive samples, there were 412
samples infected by any type of HPV identified by HPV
Genotyping, including 15 different HR-HPV genotypes.
The five most prevalent types were HPV-16(3.4%), HPV-
56(1.7%), HPV-58(1.4%), HPV-33(1.2%) and HPV-52
(0.88%), accounted for 80.1% of all HR-HPV types
detected (Table 2). When stratified by geographical area,
the most prevalent types in urban areas were HPV-16
(3.2%), HPV-56(1.5%), HPV-58(1.2%), HPV-33(1.0%) and
HPV-18(0.75%); the most prevalent types in rural areas
were HPV-16(3.6%), HPV-56(1.8%),HPV-58(1.6%), HPV-
33(1.4%) and HPV-52(0.98%). Multiple HPV infections
were identified in 50.5% (208/412) of the genotyping posi-
tive specimens, and two peaks of multiple HPV infections
were detected at 18–24 and 45–54 years age groupsrespectively. The most common combination of multiple
HPV infections was HPV-16 and −56 (50/208) followed
by HPV-16 and −58 (44/208). Of multiple HPV infections,
58.7% (122/208) were infected with two types, 26.0% (54/
208) were infected with three types, whereas 15.3% (32/
208) were infected with more than four HPV types.
Risk profile for HR-HPV infection
The socio-demographic and reproductive risk factors for
HR-HPV infection are presented in Table 3 with age-
adjusted odds ratios (OR) and 95% confidence intervals
(CI). On univariate logistic regression, women aged 30–
39 years and women living in an urban area were at
increased risk for HR-HPV infection (OR = 1.30 and 1.31;
p = 0.005). Being married or in a stable relationship, and
having an average personal family income above 4000¥
(OR=0.37 and 0.78; p < 0.0001 and p=0.013) were found
to be protective factors for HR-HPV infection.
In multivariate model, all variable from the univariate
model were included. Results of the regression model
are shown in Table 4. In the final model, parity was a
risk factor for HR-HPV infection (OR= 1.35, 95% CI:
1.18-1.53, P < 0.0001), and age of 50–65 years (OR= 0.60,
95% CI: 0.45-0.80; P= 0.0005), married or in stable rela-
tionship (OR=0.55, 95% CI: 0.31-0.96, P= 0.035) were
protective factors for HR-HPV infection.
Discussion
Differences in HR-HPV prevalence are seen between
countries. Previous studies have documented that HR-
HPV prevalence in women attending routine cervical
screening program in Europe was 15.6%. It was 13-18%
in Latin America, 17% in India and 26% in Nigeria [5],
which were much higher than the prevalence of this
study in China. To date, there has been no population-
based data in the prevalence of HR-HPV infection in
southwestern China. The present study demonstrated
that HR-HPV infection in the general female population
in Qujing is 8.3%. Compared with other studies, HR-
HPV infection in our study population is lower than that
in central China of Shanxi (12.2%), northeast China of
Shenyang (11.7%), southeast China of Zhejiang (10.2%),
and southeastern coast China of Shenzhen (13.5%) and
Taiwan (32.4%) [12-17]. However some studies that
reported even lower HR-HPV infection are the ones in
Beijing (5.8%) and our previous study in Tibet (7.1%)
Table 4 Summary of the final multivariate model (Stepwise Selection, slentry = 0.5, slstay = 0.05)
Variables β βSE Chi-Square p OR 95%CI
Intercept 1.9918 0.1214 269.0788 <.0001 - -
Parity 0.2976 0.0664 20.0954 <.0001 1.347 1.182 ~ 1.534
50-65 years old −0.5169 0.1479 12.2244 0.0005 0.596 0.446 ~ 0.797
Being married or in stable relationship −0.6044 0.2862 4.4586 0.0347 0.546 0.312 ~ 0.958
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regions because of different culture and different life
styles. One interpretation attributed to the relatively
lower prevalence of HPV infection in this study may be
that Qujing located in a close mountainous area keeping
with the traditional Chinese social habits and life styles.
Stable marital status and sexual partner may provide a
protection for HPV infection [18-22].
The persistence and clearance of HPV infection result
in the actual HPV infection rate. [23,24] Bimodal age
distribution of HR-HPV is also observed in this study.
The first peak of HR-HPV infection is obvious in women
aged 18–24 years, which may be due to primary expos-
ure to HPV after sexual initiation and lack of adaptive
immune responses in young women. [25-27] The second
peak of HR-HPV infection is observed in women aged
55–59 years which should be deserved more attention. It
is assumed that the immunologic and physiologic de-
regulation caused by hormone fluctuations may explain
the high infection rate around menopausal women
[28,29]. Nevertheless, the positive HR-HPV infection
around menopausal period women may imply the per-
sistent HR-HPV infection [28,30,31]. Therefore, HPV
detection is clinically valuable for perimenopausal
women in cervical cancer screening program. For peri-
menopausal women with positive HR-HPV DNA test re-
sult, regular follow-up and standard management should
be considered, including repeated cytology and colpos-
copy if ASCUS or more severe cytological findings were
reported, because they have higher risk for the develop-
ment of cervical cancer [18]. However, because of re-
gional economy imbalance in China, HPV testing is
currently not available in some regions, especially in
west China.
The five most common HPV types in this study were
HPV-16, -56, -58, -33 and −52 respectively. Some studies
had shown that HPV-52 and −58 were more predomin-
ant and overrepresented in cervical cancer cases in Asia
[5,12,13,15,17,32]. Data of this study revealed that HPV-
16,-56, -58, -33 and −52 may play a role in the
etiopathology of cervical cancer. Meanwhile, the high
prevalence of multiple HPV infection in this study is also
detected in young women with sexual activity as well as
in women around menopausal period. Some researches
have reported that women with multiple HPV infection
were at increased risk of precancerous lesions. [33,34]Our previous study in Tibet revealed that significant dif-
ference was evident when comparing the percentage of
abnormal cytological results in multiple HPV infection
with single HPV infection [8]. Therefore, the role of
multiple HPV infection in etiology of cervical cancer
should be further investigated, especially for the research
on HPV vaccine.
HPV vaccines have shown type-restricted prophylactic
efficacy for genital lesions. However, it does not have
clinical significance for women who have been infected
with HPV. As a result, HPV vaccine program will be of
greater benefit to younger women. We assume that the
HPV prophylactic vaccines including HPV-52 and −58
may offer higher protection for young women in China
and other Asian countries.Conclusions
This study is the first report on HR-HPV prevalence,
HPV genotypes as well as the risk factors for HR-HPV
infection in the general female population in southwes-
tern China. The baseline data of this study will contrib-
ute to making strategies for women’s health care and
implementation of cervical cancer screening program in
China.
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